Healthcare - Oncology

Companies developing cancer therapeutics, diagnostics, and precision oncology tools
LLYLLYEli Lilly & Co.
Targeted Therapy & Precision Oncology
$1.3t$1369.78-0.9%9.2K
JNJJNJJohnson & Johnson
Immunotherapy & Immuno-Oncology
$0.6t$270.59-0.8%10.5K
ABBVABBVABBVIE INC.
Immunotherapy & Immuno-Oncology
$0.5t$283.06-1.1%8.3K
MRKMRKMerck & Co., Inc.
Immunotherapy & Immuno-Oncology
$356.9b$136.55-0.8%5.3K
AZNAZNAstraZeneca PLC
Immunotherapy & Immuno-Oncology
$285.2b$176.68-1.0%7.1K
AMGNAMGNAmgen Inc
Immunotherapy & Immuno-Oncology
$249.4b$445.050.0%7.1K
GILDGILDGilead Sciences Inc
Cell & Gene Therapy for Cancer
$207.7b$167.580.0%8.5K
BMYBMYBristol-Myers Squibb Co.
Immunotherapy & Immuno-Oncology
$126.1b$59.06-0.4%8.8K
REGNREGNRegeneron Pharmaceuticals Inc
Immunotherapy & Immuno-Oncology
$100.7b$950.070.0%255
MRNAMRNAModerna, Inc. Common Stock
Immunotherapy & Immuno-Oncology
$91.2b$198.360.0%62.6K
NTRANTRANatera, Inc. Common Stock
Cancer Diagnostics & Biomarkers
$56.0b$293.050.0%2.8K
RVMDRVMDRevolution Medicines, Inc. Common Stock
Targeted Therapy & Precision Oncology
$41.6b$160.930.0%230
RPRXRPRXRoyalty Pharma plc Class A Ordinary Shares
Immunotherapy & Immuno-Oncology
$29.6b$68.930.0%146
INCYINCYIncyte Genomics Inc
Targeted Therapy & Precision Oncology
$24.0b$117.740.0%10
GHGHGuardant Health, Inc. Common Stock
Cancer Diagnostics & Biomarkers
$23.5b$146.750.0%296
EXELEXELExelixis Inc
Targeted Therapy & Precision Oncology
$17.6b$68.840.0%12.3K
JAZZJAZZJazz Pharmaceuticals, Inc.
Targeted Therapy & Precision Oncology
$14.9b$248.240.0%948
HALOHALOHalozyme Therapeutics, Inc.
Targeted Therapy & Precision Oncology
$14.6b$96.470.0%71
NUVLNUVLNuvalent, Inc. Class A Common Stock
Targeted Therapy & Precision Oncology
$9.8b$123.960.0%N/A
CAICAICaris Life Sciences, Inc. Common Stock
Cancer Diagnostics & Biomarkers
$9.3b$19.800.0%10.6K
CORTCORTCorcept Therapeutics Inc.
Targeted Therapy & Precision Oncology
$8.9b$68.500.0%437
IBRXIBRXImmunityBio, Inc. Common Stock
Immunotherapy & Immuno-Oncology
$8.8b$6.790.0%62.9K
ACLXACLXArcellx, Inc. Common Stock
Cell & Gene Therapy for CancerImmunotherapy & Immuno-Oncology
$6.7b$115.06-0.0%16.1M
LNTHLNTHLantheus Holdings, Inc
Radiopharmaceuticals & ADCs
$6.6b$102.140.0%66
GRALGRALGRAIL, Inc. Common Stock
Cancer Diagnostics & Biomarkers
$6.2b$106.300.0%1.2K
CGONCGONCG Oncology, Inc. Common stock
Immunotherapy & Immuno-Oncology
$5.7b$84.720.0%526
COGTCOGTCogent Biosciences, Inc. Common Stock
Targeted Therapy & Precision Oncology
$5.4b$28.100.0%3.2K
BLLNBLLNBillionToOne, Inc. Class A Common Stock
Cancer Diagnostics & Biomarkers
$5.2b$91.670.0%238
ERASERASErasca, Inc. Common Stock
Targeted Therapy & Precision Oncology
$5.1b$13.800.0%906
ADPTADPTAdaptive Biotechnologies Corporation Common Stock
Cancer Diagnostics & Biomarkers
$4.1b$28.550.0%526
VCYTVCYTVeracyte, Inc.
Cancer Diagnostics & Biomarkers
$4.0b$25.950.0%3.4K
IOVAIOVAIovance Biotherapeutics, Inc. Common Stock
Cell & Gene Therapy for CancerImmunotherapy & Immuno-Oncology
$4.0b$7.590.0%29.0K
ABCLABCLAbCellera Biologics Inc. Common Shares
Radiopharmaceuticals & ADCs
$3.9b$11.320.0%4.3K
TNGXTNGXTango Therapeutics, Inc.
Targeted Therapy & Precision Oncology
$3.9b$22.050.0%313
RLAYRLAYRelay Therapeutics, Inc. Common Stock
Targeted Therapy & Precision Oncology
$3.8b$16.500.0%523
PBLSPBLSParabilis Medicines, Inc. Common Stock
Targeted Therapy & Precision Oncology
$3.6b$28.640.0%1.7K
CELCCELCCelcuity Inc. Common Stock
Targeted Therapy & Precision Oncology
$3.4b$56.010.0%11.5K
ELVNELVNEnliven Therapeutics, Inc. Common Stock
Targeted Therapy & Precision Oncology
$3.2b$45.530.0%3
IDYAIDYAIDEAYA Biosciences, Inc. Common Stock
Targeted Therapy & Precision Oncology
$3.0b$26.850.0%8
NRIXNRIXNurix Therapeutics, Inc. Common stock
Targeted Therapy & Precision Oncology
$2.8b$13.750.0%547
RCUSRCUSArcus Biosciences, Inc.
Immunotherapy & Immuno-Oncology
$2.4b$16.18+1.0%4.4K
IMNMIMNMImmunome, Inc.
Targeted Therapy & Precision OncologyRadiopharmaceuticals & ADCs
$2.4b$16.890.0%1.5K
BHVNBHVNBiohaven Ltd.
Targeted Therapy & Precision Oncology
$2.4b$13.08-0.1%24.6K
XNCRXNCRXencor, Inc.
Immunotherapy & Immuno-Oncology
$2.3b$34.470.0%332
DAWNDAWNDay One Biopharmaceuticals, Inc. Common Stock
Targeted Therapy & Precision Oncology
$2.2b$21.52-0.0%3.0M
NEONEONeoGenomics, Inc.
Cancer Diagnostics & Biomarkers
$2.2b$15.520.0%1.2K
ZYMEZYMEZymeworks Inc.
Targeted Therapy & Precision Oncology
$2.2b$26.040.0%579
REPLREPLReplimune Group, Inc.
Immunotherapy & Immuno-Oncology
$2.0b$19.750.0%247
VIRVIRVir Biotechnology, Inc. Common Stock
Targeted Therapy & Precision Oncology
$1.9b$9.200.0%77
PGENPGENPrecigen, Inc. Common Stock
Immunotherapy & Immuno-Oncology
$1.9b$4.350.0%1.2K

Explore Similar Themes